1. Home
  2. Browse Decisions
  3. F.Supp.2d
  4. 968 F.Supp.2d
  5. 968 F.Supp.2d 940 (2013)
 

BIOSANTE PHARMACEUTICALS, INC. DERIVATIVE LIT.

Case No. 12 C 3480.

968 F.Supp.2d 940 (2013)

In re BIOSANTE PHARMACEUTICALS, INC. DERIVATIVE LITIGATION.

United States District Court, N.D. Illinois, Eastern Division.

September 11, 2013.

Attorney(s) appearing for the Case

Deborah R. Gross , Law Offices of Bernard M. Gross, P.C., Philadelphia, PA, James E. Barz , Robbins Geller Rudman & Dowd LLP, Chicago, IL, Benny C. Goodman, III , Erik W. Luedeke , Robbins Geller Rudman & Dowd LLP, San Diego, CA, for Plaintiffs.

Carl E. Volz , David H. Kistenbroker , Ashley John Burden , Dechert LLP, Chicago, IL, for Defendants.

MEMORANDUM OPINION AND ORDER

JOAN B. GOTTSCHALL, District Judge.

BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante developed LibiGel, a low-dose transdermal testosterone gel. LibiGel was meant to treat women with hypoactive sexual desire disorder ("HSDD"), which is a form of female sexual dysfunction ("FSD"). This shareholder derivative action against BioSante's board of directors...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases